Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesMedtronics Resolute Drug-Eluting Stent Maintains Strong, Sustained Efficacy and Safety in Long-Term Follow-Up
Medtronic, 09/22/09
The single–arm RESOLUTE trial demonstrates a low, 1.6 percent cumulative rate of target lesion revascularization (TLR) – or repeat procedures to treat the previously stented portion of the vessel – with no new TLRs between two and three years of follow–up. Cumulative rates of other clinical events remained low as well, with no new myocardial infarctions or cardiac deaths after two years.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
A Clinical Review of Echinocandins in Pediatric Patients
Annals of Pharmacotherapy, 12/16/09
Sanofi Pasteur expands study of vaccine against Clostridium difficile into the U.S.
Sanofi-aventis, 12/16/09
Second Pivotal Phase III Study of Gileads Darusentan for Resistant Hypertension Misses Primary Endpoints
Gilead, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor